| Roche Pharma (Schweiz) AG - Lunsumio 30 mg/30 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 68314 | | 02 | | Lunsumio 30 mg/30 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FX25 | | | | 09.02.2023 | | |
|
| Composition |
| Solutio concentrata: mosunetuzumabum 30 mg, histidinum, acidum aceticum glaciale, methioninum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 30 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose | additional_information |
|---|
| Mosunetuzumabum | 30mg / 30ml | Solutio concentrata |
| | BAG: Active Agent | Dose |
|---|
| Mosunetuzumabum | 30 mg |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Histidine | | Methionine | | Polysorbatum 20 | | Saccharum |
| |
|
|
